Home › Trial NCT03825289
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
- Trial IDNCT03825289
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity of Utah
- Enrollment25
- Start date2019-01-30
- ConditionsMetastatic Pancreatic Carcinoma · Stage II Pancreatic Cancer · Stage IIA Pancreatic Cancer · Stage IIB Pancreatic Cancer · Stage III Pancreatic Cancer · Stage IV Pancreatic Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.